Primary Job Title CEO Primary Organization Casma Therapeutics
Location Greater Boston Area, United States, North America Regions East Coast, New England Gender Male
LinkedIn View on LinkedIn
Keith Dionne is the Chief Executive Officer of Casma Therapeutics.
Dr. Dionne joined Constellation as President and Chief Executive Officer in March 2012 after serving as Entrepreneur-in-Residence at Third Rock Ventures. Previously, he served as CEO of Surface Logix, Inc. and as President and CEO of Alantos Pharmaceuticals, leading the
company's acquisition by Amgen in July 2007.
Prior to joining Alantos, Dr. Dionne was with Millennium Pharmaceuticals, Inc., where he held positions of increasing responsibility, concluding his seven-year tenure as both Vice President of Research and Development Strategy and Vice President and General Manager, Technology Business. Before his tenure with Millennium, Dr. Dionne served as Head of Preclinical Research & Development, implants at ALZA Pharmaceuticals. Dr. Dionne began his career in biotechnology as one of four original scientists at CytoTherapeutics, Inc.
He has served as an Adjunct Professor in the Biomedical Department at Brown University and received both a Ph.D. in chemical engineering and M.S. in the program for technology policy from Massachusetts Institute of Technology.
